Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should ARM Holdings plc (ADR) (ARMH) Be Scared of Intel Corporation (INTC) and NVIDIA Corporation (NVDA)?

After rallying to top $50 briefly in May, enjoying year-to-date gains as high as 34%, shares of ARM Holdings plc (ADR) (NASDAQ:ARMH) have pulled back dramatically and traded below $35 in June, giving up all of its gains for 2013 and then some. There have been two possible culprits contributing to the recent pessimism.

ARM Holdings plc (LON:ARM)

Intel Corporation (NASDAQ:INTC) recently scored a relatively high-profile win in Samsung’s Galaxy Tab 3 10.1 with its Clover Trail Atom chip. The spot is among the most promising mobile design wins that Intel has claimed in recent years, with the vast majority of smartphones and tablets today still powered by ARM Holdings plc (ADR) (NASDAQ:ARMH)-based chips. Clover Trail chips make significant gains in power efficiency, an area where ARM has historically had the chip giant beat.

Last month, graphics specialist and ARM Holdings plc (ADR) (NASDAQ:ARMH) licensee NVIDIA Corporation (NASDAQ:NVDA) said it would begun licensing its Kepler GPU architecture to third-party chip makers, as well as future architectures. That could incrementally expand NVIDIA’s reach into other mobile devices that aren’t powered by its Tegra processors, and NVIDIA would compete directly with ARM’s Mali GPU designs.

At least one Street analyst is unperturbed. UBS AG (USA) (NYSE:UBS) analyst Gareth Jenkins doesn’t think the new developments pose credible threats to ARM Holdings plc (ADR) (NASDAQ:ARMH)’s licensing business. Intel Corporation (NASDAQ:INTC) has made some progress expanding its mobile business, but the company still isn’t powering any mainstream devices from the top two smartphone vendors, Apple Inc. (NASDAQ:AAPL) and Samsung. Intel’s advantages in manufacturing aren’t necessarily translating into traction on the consumer level. Jenkins likewise doesn’t see NVIDIA Corporation (NASDAQ:NVDA) as a major threat immediately, saying that ARM will boost its efforts to leverage synergies offered by its CPU and GPU designs.

However, ARM Holdings plc (ADR) (NASDAQ:ARMH) has faced challenges with pairing its CPUs and GPUs at several key customers. Apple Inc. (NASDAQ:AAPL) pairs ARM CPU cores with GPU cores from Imagination Technologies, and QUALCOMM, Inc. (NASDAQ:QCOM) develops its own Adreno graphics to go along with its ARM-compatible Krait cores.

The analyst is sticking by his $44.25 price target, while boosting his rating to “buy” to reflect the pullback. Jenkins may be confident in ARM, but I still have concerns over the valuation and monetization.

The article Should ARM Holdings Be Scared of Intel and NVIDIA? originally appeared on

Fool contributor Evan Niu, CFA, owns shares of Apple and Qualcomm. The Motley Fool recommends Apple, Intel, and NVIDIA. The Motley Fool owns shares of Apple, Intel, and Qualcomm.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.